#news #biotech DiaMedica pulls off IPO to fund midphase stroke trial

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: DiaMedica pulls off IPO to fund midphase stroke trial .DiaMedica Therapeutics has wrapped up its IPO. The offering gives DiaMedica the cash to take its lead candidate through phase 2 trials in acute ischemic stroke and chronic kidney disease.

from FierceBiotech: Biotech https://ift.tt/2QC6gAy